We measured five complement biomarkers, clusterin, soluble CR1 (sCR1), C1s, C1q and FH, selected based on genetic or functional association with AD, in a cohort comprising 504 cognitively unimpaired elderly controls, 912 EOAD and 492 LOAD subjects. This evidence concerns the gene CR1 and Alzheimer disease.